Nuveen, LLC Editas Medicine, Inc. Transaction History
Nuveen, LLC
- $348 Billion
- Q2 2025
A detailed history of Nuveen, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 949,844 shares of EDIT stock, worth $2.54 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
949,844
Previous 316,614
200.0%
Holding current value
$2.54 Million
Previous $367,000
469.21%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EDIT
# of Institutions
218Shares Held
45.5MCall Options Held
476KPut Options Held
338K-
Black Rock Inc. New York, NY7.78MShares$20.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$19.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$5.24 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.88MShares$5.01 Million0.0% of portfolio
-
State Street Corp Boston, MA1.85MShares$4.93 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $184M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...